Results 241 to 250 of about 125,662 (311)

Mycophenolate Mofetil Treatment Reduces the Risk of Treatment Escalation Due to Vascular Complications in Limited Cutaneous Systemic Sclerosis: Emulation of a Target Trial From the Italian Rheumatology Society SPRING Registry

open access: yesArthritis Care &Research, EarlyView.
Objective Mycophenolate mofetil (MMF) use in limited cutaneous systemic sclerosis (lcSSc) is relatively uncommon because of the lower fibrotic burden and the predominance of vascular complications. In vitro observations and clinical data from transplanted patients suggest a protective effect of MMF on endothelial function.
Enrico De Lorenzis   +77 more
wiley   +1 more source

Heat stress and social dialogue in Spain. [PDF]

open access: yesInd Health
Salas-Nicás S, Laabbas-El-Guennouni M.
europepmc   +1 more source

Mucocutaneous Disease Activity and Damage Accrual in Systemic Lupus Erythematosus: Analyses From the Asia‐Pacific Lupus Collaboration Longitudinal Cohort Study

open access: yesArthritis Care &Research, EarlyView.
Objective This research article aims to describe the prevalence, associations, and health‐related quality of life (HRQoL) impact of mucocutaneous features of systemic lupus erythematosus (SLE). Methods Data from the Asia‐Pacific Lupus Collaboration cohort were analyzed (2013–2021).
Amanda M. Saracino   +42 more
wiley   +1 more source

A virtual consultative forum on future reforms to Better Access. [PDF]

open access: yesAust N Z J Psychiatry
Currier D   +6 more
europepmc   +1 more source

COP30: still failing to meet the challenge. [PDF]

open access: yesLancet Reg Health Eur
The Lancet Regional Health-Europe.
europepmc   +1 more source

Home - About - Disclaimer - Privacy